🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 10 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/06/2022 71,81 74,36 71,81 72,98 +0,55% 3,55% 621.400
02/06/2022 71,84 73,33 70,54 72,58 -0,03% 3,88% 424.300
01/06/2022 72,67 73,90 70,12 72,60 -0,30% 5,20% 476.400
31/05/2022 73,70 74,41 72,12 72,82 -2,45% 3,11% 603.800
27/05/2022 71,03 75,07 70,51 74,65 +5,29% 6,42% 788.400
26/05/2022 69,06 71,24 69,00 70,90 +3,52% 3,24% 596.200
25/05/2022 68,47 70,50 67,80 68,49 -0,51% 3,94% 538.200
24/05/2022 71,15 71,26 68,82 68,84 -3,87% 3,43% 650.500
23/05/2022 71,70 73,18 70,87 71,61 +0,67% 3,22% 1.059.100
20/05/2022 69,83 71,19 68,33 71,13 +2,76% 4,10% 831.400
19/05/2022 67,47 69,91 67,47 69,22 +1,10% 3,62% 825.400
18/05/2022 70,49 71,56 67,50 68,47 -3,97% 5,76% 699.200
17/05/2022 68,75 72,40 68,37 71,30 +5,58% 5,86% 708.900
16/05/2022 65,83 68,27 64,83 67,53 +2,36% 5,23% 547.100
13/05/2022 64,46 67,53 64,46 65,97 +4,25% 4,76% 887.800
12/05/2022 61,82 64,68 61,28 63,28 +0,91% 5,50% 937.900
11/05/2022 64,84 66,65 61,80 62,71 -4,14% 7,48% 1.007.400
10/05/2022 67,17 68,89 64,02 65,42 +0,40% 7,25% 1.333.700
09/05/2022 68,18 68,58 64,22 65,16 -7,13% 6,39% 1.394.000
06/05/2022 70,55 72,09 69,24 70,16 -2,13% 4,04% 840.900
05/05/2022 74,32 77,26 70,27 71,69 -1,46% 9,41% 898.000
04/05/2022 74,23 74,23 69,20 72,75 -0,79% 6,78% 943.500
03/05/2022 72,81 74,30 72,71 73,33 -0,61% 2,18% 553.900
02/05/2022 71,79 74,30 71,37 73,78 +2,02% 4,08% 536.200
29/04/2022 73,31 74,63 72,14 72,32 -2,48% 3,40% 431.800
28/04/2022 74,90 74,92 71,68 74,16 +0,22% 4,33% 447.800
27/04/2022 72,32 74,18 72,02 74,00 +1,63% 2,99% 691.100
26/04/2022 76,23 77,20 72,74 72,81 -5,07% 5,85% 710.600
25/04/2022 75,57 76,96 74,03 76,70 +0,39% 3,88% 905.300
22/04/2022 77,61 78,40 75,50 76,40 -1,23% 3,74% 655.700